280 related articles for article (PubMed ID: 9624541)
1. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
Well M; Naber KG; Kinzig-Schippers M; Sörgel F
Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
[TBL] [Abstract][Full Text] [Related]
2. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
[TBL] [Abstract][Full Text] [Related]
3. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
Infection; 1997; 25(2):121-6. PubMed ID: 9108190
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
[TBL] [Abstract][Full Text] [Related]
5. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Wydra S; Onda H; Kinzig-Schippers M; Sörgel F; Naber KG
Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
[TBL] [Abstract][Full Text] [Related]
6. Urinary Concentrations and Antibacterial Activity of BAL30072, a Novel Siderophore Monosulfactam, against Uropathogens after Intravenous Administration in Healthy Subjects.
Straubinger M; Blenk H; Naber KG; Wagenlehner FM
Antimicrob Agents Chemother; 2016 Jun; 60(6):3309-15. PubMed ID: 26976871
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin.
Naber KG; Theuretzbacher U; Moneva-Koucheva G; Stass H
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):783-9. PubMed ID: 10614952
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
Zeiler HJ; Beermann D; Wingender W; Förster D; Schacht P
Infection; 1988; 16 Suppl 1():S19-23. PubMed ID: 3286510
[TBL] [Abstract][Full Text] [Related]
9. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
10. Assessment of urinary pharmacokinetics and pharmacodynamics of orbifloxacin in healthy dogs with ex vivo modelling.
Shimizu T; Harada K; Manabe S; Tsukamoto T; Ito N; Hikasa Y
J Med Microbiol; 2017 May; 66(5):616-621. PubMed ID: 28470147
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
Infection; 1985; 13(5):219-24. PubMed ID: 2933340
[TBL] [Abstract][Full Text] [Related]
12. Urinary concentrations and antimicrobial activity of tobramycin in healthy volunteers receiving a single oral dose of a novel formulation for improved absorption.
Loose M; Naber KG; Shields P; Reinhart H; Wagenlehner FME
Int J Antimicrob Agents; 2018 Mar; 51(3):422-426. PubMed ID: 29158143
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers.
Naber CK; Hammer M; Kinzig-Schippers M; Sauber C; Sörgel F; Bygate EA; Fairless AJ; Machka K; Naber KG
Antimicrob Agents Chemother; 2001 Dec; 45(12):3524-30. PubMed ID: 11709334
[TBL] [Abstract][Full Text] [Related]
14. Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.
Wagenlehner FM; Münch F; Pilatz A; Bärmann B; Weidner W; Wagenlehner CM; Straubinger M; Blenk H; Pfister W; Kresken M; Naber KG
Antimicrob Agents Chemother; 2014; 58(2):713-21. PubMed ID: 24217699
[TBL] [Abstract][Full Text] [Related]
15. The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin.
Muranaka K; Greenwood D
J Antimicrob Chemother; 1988 May; 21(5):545-54. PubMed ID: 3134318
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
Infection; 1986; 14 Suppl 3():S203-8. PubMed ID: 3463543
[TBL] [Abstract][Full Text] [Related]
17.
Wenzler E; Meyer KM; Bleasdale SC; Sikka M; Mendes RE; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767717
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
Hostacká A
Microbios; 1997; 91(368-369):137-43. PubMed ID: 9523422
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose].
Guibert J; Kitzis MD; Acar JF
Pathol Biol (Paris); 1994 Jun; 42(6):587-92. PubMed ID: 7854859
[TBL] [Abstract][Full Text] [Related]
20. [Bactericidal activity of enoxacin and ciprofloxacin in body fluids].
Roos R; Jäger A; Kraeft H; Adam D
Infection; 1989; 17 Suppl 1():S19-20. PubMed ID: 2680990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
